The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve ...

Eric Dane not only battled ALS, but also advocated for others fighting the disease before his death. Dane’s work as an ALS ...

A scientist diagnosed with an ultra-rare form of ALS linked to a CHCHD10 gene mutation is now enrolled in a one-of-a-kind ...

Doctors across Alberta are asking the UCP government to reconsider proposed changes to its policy on medical assistance in ...

The actor's final project reveals how he fought for ALS patients behind the scenes ...

Alberta's move could unintentionally disadvantage people with neurological diseases like ALS by limiting MAID based on ...

Building on validated HIP technology, Sana Biotechnology is advancing SC451, a stem cell-derived therapy designed as a one-time treatment targeting normal blood glucose without exogenous insulin or ...

ADS-TEC Energy PLC (NASDAQ: ADSE) (the "Company"), a global leader in battery-based energy storage and fast-charging systems, today announced its preliminary and unaudited condensed consolidated finan ...

Market attention is turning to Eledon Pharmaceuticals as the company approaches a pivotal date in its financial calendar. With the clinical development of its lead candidate, Tegoprubart, advancing, ...

Mogotes Metals Inc. is pleased to announce that four drill rigs are currently drilling multiple porphyry and epithermal ...

EV Resources pushes Los Lirios toward near-term production with geophysics, 11 drill holes, and Tecomatlán plant ...